Optimization of Combined Antitumor Chemotherapy with Bevacizumab by Means of Mathematical Modeling

DOI10.1007/978-3-319-91092-5_24zbMath1401.92106OpenAlexW2886419849MaRDI QIDQ4556944

Maxim B. Kuznetsov, Andrey V. Kolobov

Publication date: 28 November 2018

Published in: Trends in Biomathematics: Modeling, Optimization and Computational Problems (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1007/978-3-319-91092-5_24

zbMATH Keywords

bevacizumabantitumor chemotherapypalliative combined chemotherapy

Mathematics Subject Classification ID

PDEs in connection with biology, chemistry and other natural sciences (35Q92) Medical applications (general) (92C50)

Cites Work

• The study of antitumor efficacy of bevacizumab antiangiogenic therapy using a mathematical model
• The Role of Cell Motility in Metastatic Cell Dominance Phenomenon: Analysis by a Mathematical Model
• Flux-corrected transport. I: SHASTA, a fluid transport algorithm that works
• Preface

This page was built for publication: Optimization of Combined Antitumor Chemotherapy with Bevacizumab by Means of Mathematical Modeling